Novo Nordisk: Valuation Reflects High Risk, But Solid Margin Of Safety (NYSE:NVO)
· seekingalpha.com
Novo Nordisk stays a Strong Buy after strong Q2 results and raised guidance. Click for more about the NVO stock.
I've been researching companies in-depth for over a decade, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emergi...